Alkermes plc
ALKS
Classement en actions
#2638
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Prix de l'action
$43.05
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$7.22B
Changement (1 jour)
4.43%
Changement (1 an)
38.95%
Pays
IE
Échange Alkermes plc (ALKS)
Catégorie
Healthcare
Nombre d'actions en circulation pour Alkermes plc (ALKS)
Nombre d'actions en circulation au June 2026: 166.61M
Selon les derniers rapports financiers et le cours de l'action de Alkermes plc, le nombre actuel d'actions en circulation est de 166.61M. À la fin de December 2023, l'entreprise avait 166.22M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Alkermes plc (ALKS) de 2000 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 166.61M | 0.74% |
| 2024 | 165.39M | -0.50% |
| 2023 | 166.22M | 1.52% |
| 2022 | 163.74M | 1.74% |
| 2021 | 160.94M | 1.35% |
| 2020 | 158.80M | 1.12% |
| 2019 | 157.05M | 1.25% |
| 2018 | 155.11M | 1.11% |
| 2017 | 153.42M | 1.27% |
| 2016 | 151.48M | 1.53% |
| 2015 | 149.21M | 2.71% |
| 2014 | 145.27M | 10.30% |
| 2013 | 131.71M | 0.00% |
| 2012 | 131.71M | 14.83% |
| 2011 | 114.70M | 19.97% |
| 2010 | 95.61M | 0.81% |
| 2009 | 94.84M | -0.34% |
| 2008 | 95.16M | -5.54% |
| 2007 | 100.74M | 1.51% |
| 2006 | 99.24M | 9.03% |
| 2005 | 91.02M | 1.03% |
| 2004 | 90.09M | 9.76% |
| 2003 | 82.08M | 27.52% |
| 2002 | 64.37M | 1.10% |
| 2001 | 63.67M | 14.21% |
| 2000 | 55.75M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 52.39% |
US
|
|
| 396.00M | 137.68% |
US
|
|
| 478.91M | 187.44% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -62.68% |
NL
|
